20 Nov
|
OncoBeta Asia Pacific
|
Australia
20 Nov
OncoBeta Asia Pacific
Australia
ONCOBETA® is a global MedTech company focused on developing and delivering cutting-edge targeted radionuclide therapies for patients with difficult-to-treat cancers. Headquartered in Germany and operating across Europe, Australia, and other international markets, ONCOBETA partners with leading clinicians, hospitals, and research institutions to expand access to precision cancer treatments. ONCOBETA's flagship therapy, Rhenium-SCT®, provides a non-surgical treatment option for non-melanoma skin cancer, helping patients achieve effective disease control while preserving function and quality of life.
YOU WILL NEED:
- Doctorate level with a medical or clinical focus (Pharm D, PhD, or MD preferred) or MSc-advanced science/clinical/healthcare related degree with relevant clinical, industry and/or dermatology or oncology experience.
- dermatology, pharmaceutical industry or medical liaison experience.
- Proven experience in peer-to-peer scientific engagement with HCPs or external experts.
- Ability to manage a field-based role with regular travel.
Job Purpose
Through in-field scientific engagement with key opinion leaders, dermatologists, skin cancer clinicians, radiation oncologists, nuclear medicine physicians, and healthcare provider networks nationally, the Medical Science Liaison (MSL) fosters an educated healthcare environment by:
- Communicating deep scientific and clinical knowledge of OncoBeta data, clinical trials (e.g., Phase IV EPIC-skin study), and radionuclide therapy mechanisms (Rhenium-188 β-radiation) to ensure evidence-based understanding of Rhenium-SCT® in treating non-melanoma skin cancer (NMSC).
- Gathering strategic clinical and operational insights regarding referral flows, safety information, and clinical evidence gaps to better understand patient needs and drive national awaremess, adoption and research.
Key Responsibilities
- Scientific Exchange & Dialogue: Engage in non-promotional, balanced 1-on-1 and group scientific exchanges with key external experts (Dermatologists, Radiation Oncologists, Nuclear Medicine Physicians, Skin GPs, Nurses) regarding Rhenium-SCT® and NMSC management in compliance with company policies and local regulatory codes.
- Site & Clinical Support: Where needed, support clinical development, registry studies, and investigator-initiated studies (IIS) by providing scientific expertise to investigators, clinical trial sites, and multidisciplinary treatment teams.
- Medical Information Requests: Respond to unsolicited technical and medical information requests from healthcare professionals regarding Rhenium-SCT dosage, tissue penetration depth (≤3 mm), safety protocols, and radiation protection in a fair, factual, and scientifically rigorous manner, aligned with OncoBeta internal processes.
- Insight Generation: Act as a critical interface between the national medical community and internal OncoBeta cross-functional teams, collating and documenting actionable field insights that will inform Medical,
Clinical Development, Commercial, and Market Access strategies.
- Cross-Functional Collaboration: Partner effectively with Commercial, Key Account, Clinical Operations and Medical Information colleagues to ensure national account strategies are patient-centric, evidence-driven, and aligned with ethical guidelines and the MTAA Code of Conduct.
- Safety Dissemination: Ensure timely and accurate communication of safety information, adverse event management (e.g., radiation dermatitis, localized skin responses), and radiation safety data to healthcare providers.
- Scientific Education & Training: Deliver internal and external scientific education, training healthcare teams and internal staff on the mechanism of action, patient selection criteria, and procedural efficacy of Rhenium-SCT®.
- Congress & Speaker Engagement: Represent OncoBeta as a scientific expert at national/international congresses and support speaker brief development for scientific symposia.
- Expertise Maintenance: Maintain an expert-level understanding of evolving literature in non-melanoma skin cancer, radiopharmaceuticals, interventional nuclear medicine, competitive treatments, and clinical guidelines.
- Compliance & Ethics: Comply strictly with OncoBeta operational standards, radiation safety guidelines, local code of conduct, and legal/regulatory requirements in all non-promotional activities.
Specific Activities
Non-Promotional Activities
- Gathering External Insights & Field Intelligence: Identify and profile key healthcare professionals (HCPs), multidisciplinary team leads, and treatment c
📌 Medical Science Liaison (Australia)
🏢 OncoBeta Asia Pacific
📍 Australia